$USAQ “We continue to strengthen our growing medical device technology and software platform with today’s announced acquisition of the AllergiEnd® intellectual properties. These properties are a great strategic fit that further support our recurring revenue business model focused on non-specialist medical practitioners, which is a large and growing addressable market. We are very well positioned in this market given our deep applications expertise and industry relationships,” said Troy Grogan, CEO of USA Equities Corp.

https://www.wsj.com/articles/usa-equities-cor...03?tesla=y